Costakos Dennis T, Greer Frank R, Love Laureen A, Dahlen Lynn R, Suttie John W
Division Neonatology, Franciscan Skemp-Mayo Health System, La Crosse, Wisconsin 54601, USA.
Am J Perinatol. 2003 Nov;20(8):485-90. doi: 10.1055/s-2003-45384.
We studied babies (22 to 32 weeks gestational age) of mothers wishing to breast-feed. Group 1 received 1 mg of vitamin K and Group 2 received 0.5 mg of vitamin K. The Day 2 plasma levels of vitamin K were 1900 to 2600 times higher on average, and the Day 10 vitamin K levels 550 to 600 times higher on average, relative to normal adult plasma values, whether an initial prophylaxis dose of 0.5 mg or 1 mg was used. We conclude that 0.5 mg as the initial dose of vitamin K intramuscularly or intravenously would likely be more than adequate to prevent hemorrhagic disease of the newborn, and that 0.3 mg/per kg may be used for babies with birth weights below 1000 g. To decrease vitamin K intakes in this population, new preparations of total parenteral nutrition multivitamins are needed.
我们研究了希望进行母乳喂养的母亲所生的婴儿(胎龄22至32周)。第1组接受1毫克维生素K,第2组接受0.5毫克维生素K。无论初始预防剂量是0.5毫克还是1毫克,相对于正常成人血浆值,第2天的维生素K血浆水平平均高出1900至2600倍,第10天的维生素K水平平均高出550至600倍。我们得出结论,0.5毫克作为维生素K的初始肌肉注射或静脉注射剂量可能足以预防新生儿出血性疾病,对于出生体重低于1000克的婴儿,可使用0.3毫克/千克的剂量。为了减少该人群的维生素K摄入量,需要新的全胃肠外营养多种维生素制剂。